Evidence map›Paper›PMID 42434389›Full record

ArticleInternational journal of microbiology2026

Gut Microbiota Differences in Down Syndrome Are Most Pronounced in Childhood and Diminish With Age.

Jesús M Pérez-Villarreal, Wendy Gastélum Espinoza, Kenia Esparza Ocampo, Alberto K De la Herrán Arita, Alma Guadrón Llanos, Carla Angulo Rojo, Loranda Calderón Zamora, Claudia Norzagaray Valenzuela, Yair Cruz-Narváez, Jaime García-Mena and 1 more

Abstract read
In one paragraph

Article in International journal of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jesús M Pérez-VillarrealPosgrado en Ciencias Biomédicas, Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico, uas.edu.mx.ORCID https://orcid.org/0000-0003-3283-562X
Wendy Gastélum EspinozaPosgrado en Ciencias Biomédicas, Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico, uas.edu.mx.ORCID https://orcid.org/0000-0002-1946-2550
Kenia Esparza OcampoPosgrado en Ciencias Biomédicas, Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico, uas.edu.mx.ORCID https://orcid.org/0000-0002-6406-9061
Alberto K De la Herrán AritaFacultad de Medicina, Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico, uas.edu.mx.ORCID https://orcid.org/0000-0002-2307-0648
Alma Guadrón LlanosFacultad de Medicina, Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico, uas.edu.mx.ORCID https://orcid.org/0000-0003-4782-6398
Carla Angulo RojoFacultad de Medicina, Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico, uas.edu.mx.ORCID https://orcid.org/0000-0002-5097-2444
Loranda Calderón ZamoraPosgrado en Ciencias Biológicas, Facultad de Biología, Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico, uas.edu.mx.ORCID https://orcid.org/0000-0001-7423-2283
Claudia Norzagaray ValenzuelaPosgrado en Ciencias Biológicas, Facultad de Biología, Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico, uas.edu.mx.ORCID https://orcid.org/0000-0001-6593-2413
Yair Cruz-NarváezEscuela Superior de Ingeniería Química e Industrias Extractivas, Instituto Politécnico Nacional, Ciudad de México, Mexico, ipn.mx.ORCID https://orcid.org/0000-0003-0956-645X
Jaime García-MenaDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Ciudad de México, Mexico.ORCID https://orcid.org/0000-0002-0595-3711
Javier Magaña GómezFacultad de Ciencias de la Nutrición y Gastronomía, Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico, uas.edu.mx.ORCID https://orcid.org/0000-0003-1081-6997

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Down syndrome (DS) is linked to increased risks of metabolic, gastrointestinal, and neurodegenerative disorders. Early alterations in the gut microbiota have potential long-term health impacts. This report appears to be the first study to stratify DS participants by age to explore early-life microbiota changes. Methodology: We conducted a cross-sectional analysis of gut microbiota in children, adolescents, and adults with DS, compared with a control group, using Illumina iSeq100 sequencing of the V4 polymorphic region of the 16S rRNA gene. Results: Children with DS exhibited lower microbial diversity and a higher abundance of genera such as Conclusion: Early alterations in gut microbiota in DS may contribute to metabolic and neurodegenerative risks, emphasizing the need for early interventions to potentially improve long-term health outcomes.

Indexed as

Down syndromeearly-life interventionsgut microbiotametabolicmicrobiota dysbiosisneurodegenerative diseaseV4-16S rRNA sequencing

Identifiers

PMID42434389
PMCPMC13351334

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.